Author: Philip Lundgren

Nordic Capital and Five Arrows have entered into a definitive agreement to sell The Binding Site, a global leader in specialty diagnostics, to Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science. The transaction is valued at GBP 2.25 billion. Since the acquisition of The Binding Site in 2011, the business has made an impressive transformation from a founder-led research-based organisation to a […] Read more

Nine months 2022 Net profit for the interim period amounted to MSEK 93.4 (107.7). Earnings per share amounted to SEK 8.40 (9.66). Net asset value amounted to MSEK 924 (SEK 83.38 per share) at September 30, 2022, compared to MSEK 823 (SEK 73.78 per share) at December 31, 2021. Net cash amounted to MSEK 244 […] Read more